MORRETTA, ELVA
 Distribuzione geografica
Continente #
AS - Asia 2.579
EU - Europa 1.820
NA - Nord America 1.586
SA - Sud America 289
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 57
OC - Oceania 3
Totale 6.429
Nazione #
US - Stati Uniti d'America 1.462
SG - Singapore 995
IT - Italia 847
CN - Cina 618
RU - Federazione Russa 582
VN - Vietnam 383
BR - Brasile 229
BD - Bangladesh 177
HK - Hong Kong 152
DE - Germania 98
CA - Canada 83
FR - Francia 79
KR - Corea 60
NL - Olanda 58
JP - Giappone 51
FI - Finlandia 36
IN - India 33
GB - Regno Unito 30
AT - Austria 29
AR - Argentina 22
MX - Messico 17
EC - Ecuador 16
PH - Filippine 15
IQ - Iraq 14
CI - Costa d'Avorio 13
UA - Ucraina 13
ES - Italia 11
ZA - Sudafrica 11
ID - Indonesia 9
TR - Turchia 9
CO - Colombia 8
MA - Marocco 8
PL - Polonia 8
TH - Thailandia 8
AZ - Azerbaigian 7
TW - Taiwan 7
NP - Nepal 6
PK - Pakistan 6
PY - Paraguay 6
BE - Belgio 5
LU - Lussemburgo 5
TN - Tunisia 5
UZ - Uzbekistan 5
CL - Cile 4
EG - Egitto 3
GA - Gabon 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
MY - Malesia 3
NI - Nicaragua 3
VE - Venezuela 3
AU - Australia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
MN - Mongolia 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CD - Congo 1
CH - Svizzera 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LB - Libano 1
LV - Lettonia 1
MW - Malawi 1
PA - Panama 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
Totale 6.328
Città #
Singapore 534
San Jose 410
Naples 363
Hefei 291
Moscow 149
Hong Kong 143
Ashburn 137
Ho Chi Minh City 95
Beijing 89
Santa Clara 89
Hanoi 88
Council Bluffs 66
Seoul 55
Lauterbourg 48
Los Angeles 46
Tokyo 45
New York 43
Rome 41
Buffalo 29
Dallas 29
São Paulo 29
Milan 25
Munich 24
The Dalles 24
Toronto 24
Phoenix 22
Nuremberg 21
Frankfurt am Main 20
Haiphong 20
Torre del Greco 20
Lappeenranta 19
Redondo Beach 17
Fisciano 15
London 15
Orem 14
Vienna 14
Chandler 13
Brooklyn 12
Da Nang 12
Kochi 12
Amsterdam 11
Bologna 11
Chicago 11
Turin 11
Turku 10
Catania 9
Montreal 9
Atlanta 8
Biên Hòa 8
Casablanca 8
Falkenstein 8
Hải Dương 8
Perugia 8
Houston 7
Kronberg 7
Palermo 7
Rio de Janeiro 7
Salerno 7
Seattle 7
Baghdad 6
Boston 6
Bắc Ninh 6
Curitiba 6
Denver 6
Formia 6
Guayaquil 6
Helsinki 6
Lawrence 6
Mexico City 6
Newark 6
San Francisco 6
San Giorgio a Cremano 6
Taichung 6
Thái Nguyên 6
Xi'an 6
Baku 5
Charlotte 5
Gaeta 5
Goiânia 5
Guangzhou 5
Joinville 5
Lucca 5
Luxembourg 5
Miami 5
Tashkent 5
Warsaw 5
Ancona 4
Ankara 4
Asunción 4
Bangkok 4
Boardman 4
Brasília 4
Brescia 4
Cagliari 4
Can Tho 4
Cuenca 4
Millbury 4
Nha Trang 4
Paris 4
Querétaro 4
Totale 3.531
Nome #
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 243
PROTEOMICS-AIDED INSIGHT TO DISCLOSE NATURAL PRODUCTS CELLULAR TARGETS 194
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- Mice 184
Boswellia serrata: a rich source of triterpenes acting as antagonists of the leukemia inhibitory factor receptor 181
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 171
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 166
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 160
Exploring Boswellia serrata Triterpenes: A New Frontier in Leukemia Inhibitory Factor Receptor Modulation 158
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 155
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 154
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity 152
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 151
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents 147
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 147
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 143
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones 139
Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone 135
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 127
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 127
Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis 125
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 125
Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid 122
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 122
RETRACTED: Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 120
Identification of Mortalin as the Main Interactor of Mycalin A, a Poly-Brominated C-15 Acetogenin Sponge Metabolite, by MS-Based Proteomics 117
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 115
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 114
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 112
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 112
Label-Free Quantitative Proteomics to Explore the Action Mechanism of the Pharmaceutical-Grade Triticum vulgare Extract in Speeding up Keratinocyte Healing 112
Triterpenes from Boswellia serrata as a New Chemotype of Leukaemia Inhibitory Factor Receptor Antagonists. 111
Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative 108
Transcriptome analysis of dual FXR and GPBAR1 agonism in rodent model of NASH reveals modulation of lipid droplets formation 108
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 106
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy 96
Interactome analysis of bioactive molecules: optimization of a label-free functional proteomics platform 94
Beneficial effects of Glc-1,6-P2 modulation on mutant phosphomannomutase-2 91
Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches 91
High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells 84
Identifying Natural Products Targetome: the case of Artemetin. 78
H3K56 acetylation affects Candida albicans morphology and secreted soluble factors interacting with the host. 78
Carbamoyl-phosphate synthase 1 as a novel target of phomoxanthone a, a bioactive fungal metabolite 69
A functional proteomics-based platform to disclose small molecules cellular targets 67
PEGylation-Driven Remodeling of the Protein Corona on PLGA Nanoparticles: Implications for Macrophage Recognition 67
Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation 63
Label-free functional proteomics links the anti-angiogenic properties of the pyrazolyl-urea GeGe-3 to Calreticulin binding. 61
Carbamoyl-Phosphate Synthase 1 as a Novel Target of Phomoxanthone A, a Bioactive Fungal Metabolite 60
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 60
Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomics 59
Discovering the biological target of 5-epi-sinuleptolide using a combination of proteomic approaches 59
Deconvolution of bioactive molecules: label-free functional proteomics to investigate the cytotoxic compound LAM20 target(s) profile 56
A bile acid–GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis 51
Functional Proteomics Ties Calreticulin with the Anti-Angiogenic Properties of the Pyrazolyl-Urea GeGe-3 51
Interactome analysis of bioactive molecules: optimization of a label-free functional proteomics platform 49
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2 49
Functional Proteomics of Quinazolin‐4‐One Derivatives Targeting the Proteasome 46
ProTide-enabled antibody-drug conjugates: A novel platform for the targeted delivery of phosphorylated drugs 42
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 41
Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis 35
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer 27
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy 23
Discovering the Biological Target of 5-epi-Sinuleptolide Using a Combination of Proteomic Approaches 16
null 3
Totale 6.429
Categoria #
all - tutte 17.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202225 0 0 0 0 0 0 0 3 3 1 8 10
2022/202366 6 3 3 1 9 5 11 5 10 5 7 1
2023/2024169 3 5 13 3 1 6 17 21 10 6 53 31
2024/20251.676 58 58 11 37 49 100 212 140 75 191 589 156
2025/20263.991 321 389 451 403 426 150 280 279 480 259 258 295
2026/2027490 179 245 66 0 0 0 0 0 0 0 0 0
Totale 6.429